Dr. Ardeshir R. Rastinehad presented “Targeted Prostate Biopsy Is the Future” at the 22nd Annual Scottsdale Prostate Cancer Symposium on Saturday, March 18, 2017.



How to cite:  Rastinehad, Ardeshir R. “Targeted Prostate Biopsy Is the Future” March 18, 2017. Accessed Jul 2024. https://grandroundsinurology.com/targeted-prostate-biopsy-future



Ardeshir R. Rastinehad, DO, is Vice Chair of Urology at Lenox Hill Hospital and System Director of Prostate Cancer at Northwell Health in New York City. He previously served as Director of Focal Therapy and Interventional Urologic Oncology and Associate Professor of Urology at Mount Sinai.

Dr. Rastinehad was the first urologist in the United States to be dual fellowship-trained in urologic oncology and interventional radiology. He specializes in the surgical management of prostate, kidney, adrenal, and testicular cancer, and is particularly interested in focal therapy for these diseases. He was the first person to perform a gold nano-particle-directed ablation for localized prostate cancer, using an electromagnetic fusion biopsy system he co-developed.

Dr. Rastinehad’s research has been published in leading national and international medical journals including The Journal of Urology, The Journal of Radiology, Urology, and The British Journal of Urology. He has also authored several book chapters.